ATTO — Attovia Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- $661.94m
- $546.81m
- $1.35m
Annual balance sheet for Attovia Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 69.3 | 152 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 0.1 | 0.9 |
| Prepaid Expenses | ||
| Total Current Assets | 72.5 | 156 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 3.23 | 7.87 |
| Other Long Term Assets | ||
| Total Assets | 76.7 | 166 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 7.72 | 11 |
| Long Term Debt | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 14.6 | 15.1 |
| Redeemable Preferred Stock | ||
| Non Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Unrealized Gain / Loss | ||
| Total Equity | 62.1 | 151 |
| Total Liabilities & Shareholders' Equity | 76.7 | 166 |
| Total Common Shares Outstanding |